Vesalius Therapeutics
PrivateLast Round
Strategic
Nov 12, 2024
Total Funding Raised
$155M
Company Overview
Vesalius Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Strategic round in November 2024.
Vesalius Therapeutics is a biotechnology company that develops a drug discovery platform to identify genetic circuits driving common illnesses and create patient-derived models for screening drug candidates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesalius Therapeutics Comparables
Compare Vesalius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Empress Therapeutics | 84% | |
| Quotient Therapeutics | 83% | |
| PrecisionLife | 82% |
For institutional investors. Book with your work email.
Vesalius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 12, 2024 | ||||
| Series A | Mar 2, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vesalius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
Yasir Al-Wakeel appointed as the new Chief Executive Officer.
- Dec 31, 2024
Partnered with GSK to develop novel therapies for Parkinson's disease.
For institutional investors. Book with your work email.
Vesalius Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vesalius Therapeutics's valuation, stock price, and market status.
Is Vesalius Therapeutics a public or private company?
Vesalius Therapeutics is a private company.
What is the current stock price of Vesalius Therapeutics?
Vesalius Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vesalius Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vesalius Therapeutics worth (valuation)?
Valuation information for Vesalius Therapeutics is not publicly available.
Can I buy Vesalius Therapeutics stock?
Vesalius Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vesalius Therapeutics's last funding round?
Vesalius Therapeutics's most recent funding round was Strategic on November 12, 2024.
Who are the main investors in Vesalius Therapeutics?
Key investors in Vesalius Therapeutics include Flagship Pioneering.
Will Vesalius Therapeutics IPO soon?
No public IPO plans have been announced for Vesalius Therapeutics.
How can I track Vesalius Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vesalius Therapeutics's shares on secondary markets.